Psoriatic Arthritis News

Repeat, routine testing for latent tuberculosis infection among patients receiving biologics is both costly and of low clinical value, according to findings presented at the 2019 ACR/ARP Annual Meeting.

ATLANTA — Age at onset of psoriasis determines whether psoriasis or psoriatic arthritis starts first in patients with psoriatic arthritis, according to data from the PsART-international web-based registry presented here.

ATLANTA — Nearly one-third of primary care providers who treat patients with arthritis failed to follow Exercise Is Medicine guidance for physical activity, according to data presented at ACR/ARP 2019.

ATLANTA — Fatigue and gastrointestinal complaints were the most common patient-reported adverse events associated with methotrexate among individuals with rheumatoid arthritis and psoriatic arthritis, according to a speaker at ACR/ARP 2019.

ATLANTA — Guselkumab, administered either every 4 or 8 weeks, is efficacious for joint and skin symptoms, as well as physical function and quality of life, among patients with active psoriatic arthritis who are biologic-naive or previously received TNF inhibitors, according to data presented at ACR/ARP 2019.

Most physicians tend to be skeptical of fad health trends. Goat yoga and appetite suppressant lollipops are shockingly — shockingly — popular in certain social media circles, but whether they actually work toward the desired end is another matter altogether.

Secukinumab is beneficial for patients with psoriatic arthritis across the spectrum of clinical phenotypes for the disease, according to findings published in the Journal of Rheumatology.

Rheumatology patients treated with interleukin inhibitors have an increased risk for serious infections, opportunistic infections and cancer, according to data published in JAMA Open Network.

Ixekizumab is superior to adalimumab in simultaneously improving both joint and skin disease in patients with psoriatic arthritis who have had an inadequate response to conventional synthetic DMARDs, according to data published in the Annals of the Rheumatic Diseases.

The majority of physical therapists can accurately distinguish between inflammatory and noninflammatory arthritis and understand the importance of correct and prompt referrals to a rheumatologist for suspected inflammatory conditions, according to survey results published in Arthritis Care & Research.